Bersabe, Mildred M.
HRN: 09-34-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2022
CEFUROXIME 1.5GM (VIAL)
08/18/2022
08/18/2022
IV
1.5gm
On Call To OR
Prophylaxis For Completion Curettage
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes